Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
COYA on Nasdaq
Shares outstanding
20,908,887
Price per share
$4.72
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
7,939,025
Total reported value
$46,046,406
% of total 13F portfolios
0%
Share change
+3,207,021
Value change
+$18,616,631
Number of holders
58
Price from insider filings
$4.72
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DME Capital Management, LP 9.9% $10,783,903 1,651,440 DME Advisors GP, L.L.C. 31 Dec 2024
HIRSCHMAN ORIN 5.3% -34% $6,427,392 -$1,309,338 1,108,171 -17% Orin Hirschman 31 Dec 2025
VANGUARD GROUP INC 4.3% $5,215,012 899,140 The Vanguard Group 31 Dec 2025

As of 31 Dec 2025, 58 institutional investors reported holding 7,939,025 shares of Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA). This represents 38% of the company’s total 20,908,887 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA) together control 36% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
DME Capital Management, LP 9.7% 2,025,940 +23% 0.41% $11,750,452
AIGH Capital Management LLC 4.7% 975,404 -12% 1.7% $5,657,343
VANGUARD GROUP INC 4.3% 899,140 +7.5% 0% $5,215,012
Alyeska Investment Group, L.P. 3.8% 800,000 0.01% $4,640,000
AWM Investment Company, Inc. 3.5% 725,000 0.41% $4,205,000
CM Management, LLC 1.7% 350,000 +17% 1.7% $2,030,000
PRIVATE MANAGEMENT GROUP INC 1.3% 280,267 0.05% $1,625,549
MARSHALL WACE, LLP 1.1% 225,358 +439% 0% $1,307,078
GEODE CAPITAL MANAGEMENT, LLC 0.95% 197,988 +26% 0% $1,148,583
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.6% 124,831 +274% 0% $724,019
JBF Capital, Inc. 0.48% 100,006 0.08% $580,035
683 Capital Management, LLC 0.38% 80,128 0.04% $464,742
BlackRock, Inc. 0.38% 79,146 +13% 0% $459,047
STATE STREET CORP 0.33% 69,510 +45% 0% $403,158
RENAISSANCE TECHNOLOGIES LLC 0.32% 66,900 +92% 0% $388,020
Squarepoint Ops LLC 0.31% 65,150 0% $377,870
Point72 Asset Management, L.P. 0.29% 61,584 0% $357,187
MORGAN STANLEY 0.26% 53,356 +3399% 0% $309,465
PRELUDE CAPITAL MANAGEMENT, LLC 0.25% 52,270 +46% 0.02% $303,166
NORTHERN TRUST CORP 0.19% 40,418 +25% 0% $234,424
BANK OF AMERICA CORP /DE/ 0.19% 39,784 +18404% 0% $230,747
Long Corridor Asset Management Ltd 0.19% 38,766 0.11% $224,843
Walleye Capital LLC 0.18% 37,062 0% $214,960
WESTWOOD HOLDINGS GROUP INC 0.18% 36,660 0% $212,628
UBS Group AG 0.17% 35,035 +163% 0% $203,203

Institutional Holders of Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 7,939,025 $46,046,406 +$18,616,631 $5.80 58
2025 Q3 4,755,804 $27,110,326 +$1,543,439 $5.70 35
2025 Q2 4,484,686 $25,787,239 -$1,022,977 $5.75 33
2025 Q1 4,662,591 $30,167,676 +$1,480,613 $6.47 26
2024 Q4 4,444,580 $25,467,940 +$6,454,839 $5.73 26
2024 Q3 3,315,161 $21,385,210 +$304,078 $6.45 19
2024 Q2 3,268,292 $19,805,900 -$932,467 $6.06 19
2024 Q1 3,339,060 $33,123,748 +$5,311,359 $9.92 19
2023 Q4 2,822,037 $20,644,859 +$10,288,077 $7.41 20
2023 Q3 1,416,355 $5,449,280 +$229,488 $3.84 14
2023 Q2 1,351,642 $5,500,530 +$1,016,457 $4.07 13
2023 Q1 1,101,849 $4,368,596 +$41,079 $3.97 7
2022 Q4 1,091,417 $5,156,354 +$5,156,354 $4.74 4